Comparing the Quality of Life in Patients with Stroke Under the Treatment with and Without Recombinant Tissue Plasminogen Activator
Background: Stroke has been considered one of the most common life-threatening neurological disease and a global health problem. It causes disability in adults and ranked as the third leading causes of human mortality worldwide. Objectives: The aim of this study was to compare the quality of life in...
Main Authors: | Zahra Goudarzi, Zhila Najafpour, Nahid Hatam |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2019-06-01
|
Series: | Health Technology Assessment in Action |
Subjects: | |
Online Access: | https://htainaction.tums.ac.ir/index.php/hta/article/view/15 |
Similar Items
-
Acute Ischemic Stroke in Term Pregnancy Treated with Recombinant Tissue Plasminogen Activator
by: Sanjith Aaron, et al.
Published: (2020-12-01) -
Does intravenous administration of recombinant tissue plasminogen activator for ischemic stroke can cause inferior myocardial infarction?
by: Mostafa Almasi, et al.
Published: (2016-06-01) -
The Outcome of Treatment with Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke
by: Alia Saberi, et al.
Published: (2021-07-01) -
Rheumatoid meningitis presenting with a stroke-like attack treated with recombinant tissue plasminogen activator: a case presentation
by: Masashi Akamatsu, et al.
Published: (2018-09-01) -
Effect of Tissue Plasminogen Activator on Treatment Outcome and Neuronal Degeneration in Acute Ischemic Stroke
by: Muhammad Masoud, et al.
Published: (2021-01-01)